Sekisui

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News

Lonza Further Invests in Drug Product Manufacturing Capabilities

New filling line to process various modalities, including monoclonal antibodies, bioconjugates, viral vectors, and other gene therapy products.

09.22.21

BioVaxys Reports Progress on Covid-19 Vax Candidate

Bioproduction partner Wuxi Biologics completes synthesis of recombinant SARS-CoV-2 s-proteins for BVX-0320 and CoviDTH programs.

09.16.21

Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News

Clean Cells Expands Bioproduction Capabilities

Invests $15.3 million in new biopharmaceutical production site.

09.16.21

Breaking News | Facilities | Industry News | Inspections

Symbiosis Completes Successful MHRA Audit

Will expand facility at its Stirling, UK site with new storage and warehousing capability.

09.16.21

Emergent BioSolutions, Providence Therapeutics Enter Vaccine Manufacturing Partnership

Ink multi-year development and manufacturing agreement for mRNA COVID-19 vaccine candidate, PTX-COVID19-B.

09.14.21

AGC Biologics Expands pDNA and mRNA Manufacturing Capacity

Expansion at Heidelberg site allows the CDMO to meet increasing demands of the cell and gene therapy market.

09.14.21

Breaking News | Industry News

Samsung Biologics to Participate in Frontier 1.5D Initiative

Will develop a climate risk management model as part of 2050 Carbon Neutral Strategy in response to the challenges associated with climate change.

09.14.21

Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News

FUJIFILM Diosynth Biotechnologies, NeuExcell Enter Gene Therapy Mfg. Pact

Aims to rapidly advance NXL-001, a potential neuro-regeneration gene therapy to treat ischemic cortical stroke.

09.13.21

Breaking News | Formulation Development

AzurRx BioPharma Acquires First Wave Bio Inc.

Expands its GI development pipeline and positions itself for new growth opportunities in the inflammatory bowel disease therapeutic space.

09.13.21

Antimicrobial Resistance ‘Arms Race’ Realizes Advancements as Post-Antibiotic Era Ensues

Emerging innovations and non-antibiotic approaches to address urgent need to control infectious diseases, including multiple-drug resistant ‘super-bugs’.

Merilee Kern, MBA, Brand Analyst, Strategist and Futurist, and Forbes Business Council Member 09.09.21

Trust, but Verify

Or, R.I.P, CoA.

Emil W. Ciurczak, DoraMaxx Consulting 09.09.21

APIs | Solid Dosage/Creams/Ointments

Spray Drying: A Proven Approach to Enhance the Solubility of APIs

Spray drying is an established particle engineering technology that offers several advantages over other methods used for improving API bioavailability.

Benzion Dolitzky, PhD, VP R&D, Wavelength Pharmaceuticals 09.09.21

Logistics | Supply Chain

Maintaining Critical Drug Supply During COVID-19

Vincent Colicchio from Dr. Reddy’s talks about the challenges and solutions of maintaining supply during the pandemic.

Tim Wright, Editor, Contract Pharma 09.09.21

Analytical Services | Bioanalytical Services

Putting Laboratory Suppliers to the Test in the COVID Era – and Beyond

Build resiliency into analytical methods through careful consideration of chromatography partners.

Hazel Dickson, PhD, Marketing Manager, Chemistry Group, Waters Corporation 09.09.21

Choosing and Managing a CDMO

Speed up your time-to-market, keep development costs under control and smooth the FDA approval and commercial launch process.

Dana Toops, President, Avema Pharma Solutions 09.09.21

Breaking News | Promotions & Moves

Orchard Therapeutics Appoints New Leadership

Names new chief scientific officer, chief technical officer and chief medical officer.

09.09.21

Bio News | Breaking News | Facilities | Industry News

Olon to Expand Italian Biomanufacturing Site

Will allow the company to increase its capacity to accommodate new and existing clients' needs.

09.08.21

Breaking News | Industry News

Citius Acquires Cancer Drug Asset from Dr. Reddy's

Expands late-stage pipeline with the acquisition of exclusive license rights to E7777, an improved formulation of previously FDA-approved ONTAK.

09.08.21

FairJourney Biologics Expands into New Facilities

Newly purpose-built research center in Porto, Portugal supports rapid expansion.

09.01.21

Biologics, Proteins, Vaccines | Breaking News

Avantor Commences Multi-Year Investment in Global Hydration Capabilities

Completes a major expansion of its facility in Gliwice, Poland, and begins a multi-stage expansion of its facility in Aurora, Ohio.

08.31.21

Breaking News | Industry News | Promotions & Moves

Forge Biologics Expands Leadership Team

Announces two key hires in process development and medical affairs.

08.30.21

Breaking News | Drug Development | Industry News

Innovent Biologics, Bolt Biotherapeutics Enter Immuno-oncology Alliance

Will leverage Innovent's therapeutic antibody portfolio and discovery capability against undisclosed oncology targets in combination with Bolt's ISAC technology

08.27.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Drug Discovery | Industry News

Heat Biologics Launches New Drug Discovery Subsidiary

Will focus on the development of a drug discovers paradigm to enable rapid drug development.

08.26.21

EOC Pharma and Chime Biologics Extend Partnership

For the CMC development of EOC202, a recombinant LAG-3 protein for cancer immunotherapy.

08.26.21

FDA Approves Pfizer-BioNTech COVID-19 Vaccine COMIRNATY

Grants first full approval for COVID vaccine.

08.23.21

Bio News | Breaking News | Industry News

Pfizer to Acquire Trillium Therapeutics for $2.3B

Strengthens oncology portfolio with addition of next-generation, investigational immuno-therapeutics for hematological malignancies.

08.23.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News

AGC Biologics Breaks Ground on New Facility

Multipurpose facility at the CDMO’s Copenhagen, Denmark site will include a manufacturing building, an office building and a visitors center.

08.23.21

cGMP Manufacture | Fill/Finish | Parenterals

Modularity in Injectables Manufacturing

Raffaele Pace of Stevanato Group discusses injectable trends, challenges for manufacturers, and solutions for production customization.

Kristin Brooks, Managing Editor, Contract Pharma 08.19.21

Breaking News | Facilities | Industry News | Solid Dosage/Creams/Ointments

Alladapt Initiates Buildout of New Manufacturing Facility

For production of novel, investigational oral immunotherapeutic designed to treat food allergies.

08.19.21

Bio News | Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News

Beroni Begins Manufacture of Anti-Cancer Drug PENAO

Inks contract manufacturing deal with Aurigene Pharma Services.

08.19.21

Drug Development | Drug Discovery

Antimicrobial Resistance ‘Arms Race’ Realizes Advancements as Post-Antibiotic Era Ensues

Emerging innovations and non-antibiotic approaches to address urgent need to control infectious diseases, including multiple-drug resistant ‘super-bugs’

Merilee Kern 08.18.21

Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News

Syngene Expands Biopharma Manufacturing Capacity

Sets up a state-of-the-art microbial facility; expands mammalian facility.

08.17.21

Breaking News | Industry News

Bora Names Sally Langa Global SVP Sales and Marketing

Langa is recognized throughout the industry for delivering diverse and profitable growth.

08.13.21

Breaking News | Promotions & Moves

Catalent Appoints GM of Philadelphia Clinical Supply Facility

Harold A. Jenkins III brings more than 28 years of leadership experience.

08.13.21

Clinical Trials | Cold Chain Management | Logistics

Flexible Ultracold Chain Critical to Decentralized Clinical Trials

Addressing barriers to further grow and accelerate the adoption of patient-focused DCTs.

Timothy Root, Marketing Director, Stirling Ultracold 08.12.21

Biologics, Proteins, Vaccines | Breaking News

Evotec Opens cGMP Manufacturing Facility in Redmond, WA

Expands capabilities into commercial biologics manufacturing and adds late stage clinical development and commercial supply for drug substance.

08.11.21

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News

Lumen Bioscience, Google Partner to Apply ML to Biologics Manufacturing

Aims to double biomanufacturing productivity.

08.11.21

CMO Becoming a Powerhouse With Expansions and New Facilities, Looking to Add Strategic Customers

Aphena is a service provider in the pharmaceutical, OTC, medical device, biologics and personal care industries.

Breaking News | Industry News

Catalent, Edenbridge Pharma Enter Zydis Formulation Supply Agreement

Novel formulation of glycopyrrolate will use Catalent’s Zydis ODT delivery technology for adjunctive therapy for the treatment of peptic ulcer.

08.10.21

Breaking News | Industry News | Logistics

Aphena to Launch New Third-Party Logistics Division

New 3PL Division, to begin serving clients in early 2022, will be based at the company’s Cookeville, TN, campus.

08.10.21

Biologics, Proteins, Vaccines | Drug Delivery | Drug Development

VideoBites: Catalent

Catalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics and more.

Biologics, Proteins, Vaccines | cGMP Manufacture

A Look Into COVID Vaccines, Development and Outsourcing

Fiona Barry of PharmSource discusses COVID vaccines in development and CMO outsourcing trends.

08.09.21

Analytical Services | Bioanalytical Services | Breaking News | Industry News | Laboratory Testing

Frontage Opens New Lab Facility in Exton, PA

New 71,000 sq.-ft., state-of-the-art facility will support increased demand for CMC and biologics services.

08.09.21

cGMP Manufacture | Drug Development | Promotions & Moves

Syngene Adds Senior Leadership in the U.S.

Alex Del Priore appointed Senior Vice President, Manufacturing Services, and Alan Collis appointed Vice President, Integrated Drug Discovery Services.

08.06.21

Breaking News | Industry News | Promotions & Moves

Stelis Biopharma Appoints Mark Womack as CEO

Assumes the role of chief executive with immediate effect and will be stationed at Stelis HQ in Bengaluru, India.

08.06.21

Breaking News | Facilities | Industry News

TriRx Completes Acquisition of Elanco Animal Health Facility

Site in Shawnee, KS to become a global center of excellence serving the pharmaceutical contract development and manufacturing market.

08.06.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News

Amgen Investing $550M in New Biomanufacturing Facility

Will create 355 new jobs at Holly Springs, NC site.

08.05.21

The Real Cost of Bringing Manufacturing Home

Bikash Chatterjee of Pharmatech Associates discusses the reshoring trend, technologies and advances that could help deliver more manufacturing back to the U.S.

08.04.21

CPhI North America Event Info

...

08.03.21

Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News | Solid Dosage/Creams/Ointments

DisperSol, Catalent Enter Manufacturing Collaboration

To establish KinetiSol technology manufacturing hub for DisperSol’s pipeline.

08.03.21

IDT Biologika

IDT Biologika specializes in the contract development and manufacturing of Viral Vaccines, Gene and Immunotherapeutics and more.

07.29.21

Breaking News | Financial Reports

Pfizer's 2Q Revenues Up 92%

COVID-19 vaccine BNT162b2 contributes $7.8 billion in sales and alliance revenues.

07.29.21

Breaking News | Facilities | Industry News

Celanese Opens Pharma Drug Delivery Feasibility Lab

State-of-the-art R&D lab at Florence, KY site expands technical feasibility capabilities for long-acting delivery of small molecules, biologics and nucleotides.

07.29.21

Abzena, BioXpress Therapeutics Enter Biosimilar Tie-up

Partnership to support the development and manufacture of biosimilars for global customers.

07.29.21

Breaking News | Industry News

Amgen to Acquire Teneobio for $900M

Includes Teneobio's bispecific and multispecific antibody technologies, heavy-chain only platform and T-cell engager platform.

07.28.21

Bio News | Breaking News | Collaborations & Alliances | Industry News

AavantiBio, Aldevron Form Gene Therapy Partnership

Aldevron will supply plasmids to AavantiBio’s planned vector core and CDMO partners.

07.27.21

Breaking News | cGMP Manufacture | Industry News

WuXi Biologics Receives Manufacturing License from German Health Authorities

The inspections comprised areas of cGMP manufacturing required for receiving the permit, as well as commercial production approval.

07.26.21

Breaking News | Facilities

Capsida Biotherapeutics Opens Facility in Thousand Oaks

New 15,000 square-foot facility will enable industry leading end-to-end gene therapy manufacturing capability.

07.23.21

Bio News | Breaking News | Industry News

Catalent Biologics Launches GPEx Lightning Cell Line Expression Technology

Designed to shorten drug substance development timelines by up to three months.

07.22.21

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News

Catalent Plans $100M Expansion of Biologics Mfg. Capabilities in Italy

Initial phase includes installation of two 2,000-liter single-use bioreactors and associated investments to support early-and late-phase clinical development.

07.21.21

Samsung Biologics, Kineta Enter Development and Manufacturing Agreement

Samsung's San Francisco R&D center and South Korea headquarters to offer end-to-end CDMO service for anti-VISTA antibody immunotherapy.

07.20.21

Breaking News | cGMP Manufacture | Cytotoxics and High Potency Manufacturing | Industry News

Lonza Extends Large-Scale MAb Commercial Supply Pact

To provide commercial-scale manufacture of monoclonal antibodies under a long-term agreement at Visp site.

07.19.21

Astellas

...

07.16.21

Boehringer-Ingelheim

...

07.16.21

Bio News | Breaking News | Industry News | Promotions & Moves

Vibalogics Advances Growth with Leadership Hires

Pharma industry vet Roger Lias joins the CDMO as chief commercial officer.

07.16.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Industry News

GentiBio, Forge Biologics Ink Development and Manufacturing Agreement

Partnership to support GentiBio’s cell therapy pipeline with AAV process development, scale up and GMP manufacturing services.

07.16.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News

Curia to Acquire US-based LakePharma

Expanding end-to-end R&D capabilities and scale for biologics.

07.14.21

Curia to Acquire Integrity Bio

Expands biologic formulation and fill-finish capabilities.

07.13.21

I-Mab Expands Next-Gen Novel Oncology Portfolio

Expands pipeline of antibody assets leveraging cutting-edge mRNA and AI technology platforms.

07.09.21

Aseptic Processing | Breaking News | Fill/Finish | Industry News | Parenterals

Swiss Government Turns to Swissfillon for COVID-19 Test Kit Production

Drug product CMO specialist adapts to provide 0.8 million prefilled syringes.

07.08.21

Breaking News | Promotions & Moves

Thermo Fisher Names New Chief Medical Officer

Alan Sachs will assume the newly established role.

07.07.21

Collaborations & Alliances | Drug Development

Y-Biologics, Pierre Fabre Enter Immuno-oncology Alliance

Aims to develop and commercialize a family of human antibodies to inhibit the growth of tumor cells.

07.07.21

Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Cytotoxics and High Potency Manufacturing | Industry News

Novasep, Exelixis Ink ADC Manufacturing Agreement

Covers the cGMP clinical manufacturing of a next-generation ADC drug candidate.

07.06.21

Breaking News | Promotions & Moves

Avid Bioservices Appoints Esther M. Alegria to Board

Former SVP of global manufacturing at Biogen bring nearly 30 years of biopharmaceutical industry experience.

07.02.21

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News

AGC Biologics to Acquire Novartis Facility in Longmont, CO

Significantly expands cell and gene therapy capabilities and offerings.

07.02.21

Breaking News | Collaborations & Alliances | Industry News

Innovent Biologics Signs License Agreement with Synaffix

Synaffix will provide proprietary ADC technologies to enable Innovent to rapidly progress one of its antibodies as a best-in-class ADC candidate.

07.01.21

Breaking News | Drug Development

CureVac Appoints Dr. Malte Greune as COO

Dr. Florian von der Mülbe will shift focus exclusively toward the expansion and accelerated development of The RNA Printer.

06.30.21

Ninth Annual Optimizing Bioassays for Biologics

...

06.29.21

Analytical Services | Bioassay Development | Biologics, Proteins, Vaccines | Drug Development

Host Cell Impurities, Bioassays, Micro-Flow Imaging

WHO, FDA and the European Pharmacopoeia have established strict regulatory guidelines to guarantee product quality in biologics.

Microbiology

On-Demand Webinar: Microbial In-Use Studies

In this webinar, Alcami’s Brent Harlow will guide you through the necessity of these studies and how to successfully perform them for FDA approval.

APIs | Drug Development | Formulation Development

QBD Addresses API Supply in Orphan Drug Formulation

Due to the high costs and low demands of the drug product, it is important to efficiently use API supply during the formulation process.

Formulation Development

Tryp Therapeutics Partners with Alcami for Proprietary Formulations

The agreement represents another step toward the proprietary manufacturing, formulation, and delivery of products for Tryp’s PFNTM program.

Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News | Process Development

Catalent to Acquire RheinCell Therapeutics

Strengthens path towards industrialization of induced pluripotent stem cell-based therapies.

06.25.21

Cobra Biologics, CombiGene Ready to Start GMP Production of Epilepsy Drug Candidate

Complete production and quality assurance of the plasmids to be used in the GMP production of CG01.

06.25.21

Breaking News | Clinical Trial Materials

Chemomab and AGC Biologics Partner to Manufacture CM-101 for Phase II/III

AGC Biologics will manufacture the clinical trial materials at its site in Copenhagen to support clinical testing and launch readiness.

06.24.21

Lonza and ValenzaBio Enter Clinical Manufacturing Agreement

Lonza will provide drug substance and drug product manufacturing under accelerated timelines for monoclonal antibody treatment at Guangzhou facility.

06.21.21

Breaking News | Industry News | Laboratory Testing

Solvias Acquires Chemic Labs

Establishes U.S. lab presence and expands testing services.

06.18.21

APIs | Supply Chain

Maintaining Critical Drug Supply During the Pandemic

Vin Colicchio from Dr. Reddy’s talks about the challenges and solutions of maintaining supply during the pandemic.

Tim Wright, Editor, Contract Pharma 06.17.21

Breaking News | Facilities | Industry News | Lyophilization

Horizon Therapeutics Buys EirGen Manufacturing Facility

The 44,000 square foot facility in Ireland includes fill-finish and analytical laboratory capabilities with potential for site expansion.

06.17.21

Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News

Sanofi Invests $425M in Flu Vaccine Manufacturing Facility

Newly licensed U.S. manufacturing facility to increase availability of Fluzone High-Dose Quadrivalent.

06.17.21

Breaking News | Facilities

Thermo Scientific Upgrades Ultra-Low Temperature Freezers

The TSX Series ULT Freezers reliably preserve stored materials in an environmentally and user-friendly design.

06.16.21

Breaking News | Collaborations & Alliances | Drug Development | Formulation Development

Lumen Bioscience, Novo Nordisk Enter Metabolic Research Pact

To explore Lumen's drug development and manufacturing platform to deliver oral biologics for cardiometabolic disease.

06.16.21

Breaking News | Promotions & Moves | Solid Dosage/Creams/Ointments

Recro Expands Board of Directors

Welcomes Dr. Laura L. Parks to the board.

06.16.21

Dendreon Pharmaceuticals Establishes Contract Manufacturing Division

Now offers end-to-end manufacturing of complex cell therapies and patient logistics for partner programs.

06.15.21

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News

Yposkesi to Build Second Commercial Bioproduction Site

Creates a new global resource for cell & gene therapy with production capacity for early clinical to commercially available biologics.

06.14.21

Establishing Commercial Manufacturing Services for Antibody-Drug Conjugates

Learn how to properly structure your development work, perform a thorough process risk assessment and prepare for pre-approval inspection audit.

Yourway Breaks Ground on Major Expansion at Pennsylvania HQ

The project includes a new Phase I clinical trials unit.

06.09.21

Breaking News | Industry News | Promotions & Moves

Symbiosis Names Jette Cowan Biz Development Manager

Will build relationships with new and existing clients across the Nordic region and Germany.

06.09.21

Bioprocessing Technologies: Stainless Steel vs Single Use

Join us on June 22 for a brief introduction of the current competing market between stainless steel and single use systems.

06.09.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

AGC Biologics Inks Supply Deal for COVID-19 Vaccine

CDMO’s Heidelberg facility to supply plasmid DNA for Pfizer/BioNTech COVID-19 vaccine.

Tim Wright, Editor, Contract Pharma 06.07.21

Portonbio Enters CAR-T Partnership with KAEDI

CDMO will provide KAEDI with CMC services for multiple projects.

Tim Wright, Editor, Contract Pharma 06.07.21

Facilities | Solid Dosage/Creams/Ointments

Newsmakers: Lynn Allen, Vice President of Business Development, MedPharm

Newly expanded labs bolster testing, formulation development, and manufacturing services.

Tim Wright, Editor, Contract Pharma 06.03.21

Breaking News | Industry News

Biovectra Inc. Unveils New Logo and Brand

New image reflects the growing company’s full suite of expertise and core values.

Charles Sternberg, Assistant Editor 06.03.21

Bio News | Breaking News | Collaborations & Alliances | Industry News

Samsung Biologics Signs Agreement with Kahr Medical

Will support Kahr’s drug candidate DSP502, a TIGITxPD1 fusion protein.

Charles Sternberg, Assistant Editor 06.03.21

Breaking News | Fill/Finish | Industry News

Selkirk Pharma Begins Construction of Injectable Mfg. Facility in Spokane

New fill and finish facility will add critically needed capacity for the manufacture of commercial and clinical trial drugs.

Kristin Brooks 06.02.21

Bioanalytical Services | Bioassay Development | Biologics, Proteins, Vaccines

The Future of Continuous Bioprocessing

The modernization of advanced therapy manufacturing.

Dr. Karoline Hahn, Senior Consultant for Advanced Therapies, KCR 06.02.21

Promotions & Moves

Selexis SA Appoints Hoffmann-Hecht CBO

Dr. Hoffmann-Hecht will serve on the executive leadership team and will report to Selexis CEO Dirk Lange.

Kristin Brooks 06.02.21

Samsung Biologics Expands Vaccine Manufacturing Capabilities

To add mRNA vaccine drug substance manufacturing suite to expand portfolio of services.

Tim Wright, Editor, Contract Pharma 06.01.21

Bioanalytical Services | Biologics, Proteins, Vaccines

The Future of Continuous Bioprocessing

The Modernization of Advanced Therapy Manufacturing

Dr. Karoline Hahn, Senior Consultant for Advanced Therapies, KCR 05.27.21

Breaking News | Collaborations & Alliances | Industry News

Hovione and iBET Form Strategic Collaboration

Will combine knowledge from both partners to create innovation in new therapeutic fields.

Tim Wright, Editor, Contract Pharma 05.27.21

Bio News | Breaking News | Collaborations & Alliances | Industry News

The Discovery Labs Signs Lease with UPenn's Gene Therapy Program

The University will use Discovery Labs’ campus for a portion of its research operations focused on the development of genetic medicines.

Charles Sternberg, Assistant Editor 05.27.21

Biologics, Proteins, Vaccines | Clinical Trials | Drug Development

Gene Therapy Trials

Critical regulatory and study start-up questions for gene therapy trials in the U.S., UK, and Europe.

April Marquick, Cell and Gene Therapy Expert, Premier Research 05.26.21

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News

CanSino Biologics Gets OGYÉI GMP Certificate for COVID Vax

Convidecia has been approved in China, Mexico, Pakistan, Hungary and Chile.

Kristin Brooks 05.24.21

Breaking News | Facilities | Industry News | Lyophilization

Argonaut Expands Lyophilization Facility

Enhances manufacturing capabilities with major investment in lyophilization facility expansion.

Tim Wright, Editor, Contract Pharma 05.21.21

Breaking News | Industry News | Vials

HERMA US Delivers Wrap-around Labelers to Catalent

Will support production of biologics, including COVID-19 vaccines.

Kristin Brooks 05.18.21

Breaking News | Drug Delivery | Industry News

BD to Build $200M PFS Mfg. Facility in Spain

New site is part of a $1.2 billion investment over four years to expand and upgrade manufacturing capacity and technology for pre-fillable syringes.

Kristin Brooks 05.18.21

Bio News | Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | Industry News

PerkinElmer Acquires Nexcelom Bioscience

Bolsters preclinical portfolio and enhances QA/QC capabilities in cell and gene therapy and biologics manufacturing.

Tim Wright, Editor, Contract Pharma 05.17.21

Humanigen Selects Chime Biologics as Manufacturing Partner

Ink manufacturing deal for COVID-19 therapeutic candidate lenzilumab.

Tim Wright, Editor, Contract Pharma 05.17.21

Biologics, Proteins, Vaccines | Breaking News | Industry News

Avantor Boosts Global Production of Single Use Technologies

To increase single-use manufacturing footprint by 30% and double its cleanroom space in the U.S. and Europe.

Kristin Brooks 05.14.21

Avantor Expands Global Production of Single-Use Technologies

To increase single-use manufacturing footprint by 30% and double cleanroom space.

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News

WuXi Biologics, WuXi STA Establish WuXi XDC JV

To provide contract development and manufacturing of bioconjugates including antibody-drug conjugates (ADCs).

Kristin Brooks 05.14.21

Breaking News | Promotions & Moves

Capsida Biotherapeutics Appoints CMO

Dr. Tole brings extensive drug development experience in the biotech industry across a wide spectrum of disease areas.

Kristin Brooks 05.12.21

Breaking News | Industry News | Promotions & Moves

Woodstock Sterile Solutions Names Oliver Vogt as VP and General Manager

Will be responsible for Woodstock’s manufacturing business as well as leading its supply chain and site operations.

Charles Sternberg, Assistant Editor 05.11.21

Aenova Expands Capacity for Fill & Finish of Vaccines and Biologics

New €16M area for sterile production including vaccine fill and finish is being built at the Aenova site in Latina, Italy.

Tim Wright, Editor, Contract Pharma 05.07.21

Bio News | Breaking News | Collaborations & Alliances | Drug Development | Industry News

3P and Buzzard Pharmaceuticals Enter Cancer Collaboration

Enter into a partnership agreement for manufacturing of the potent IL-1 inhibitor Isunakinra.

Charles Sternberg, Assistant Editor 05.07.21

Bio News | Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News

AGC Biologics and Oculis Enter Manufacturing Deal

AGC to manufacture Oculis’ OCS-02 at its Heidelberg facility.

Tim Wright, Editor, Contract Pharma 05.07.21

The Word ‘Innovation’ Probably Doesn’t Mean What You Think It Does

Innovation in manufacturing can come in many forms.

Ben Locwin, Contributing Editor, International COVID-19 Advisor, Healthcare Futurist 05.05.21

CDMO Market Trends & Opportunities

CDMOs have been some of the biggest winners from COVID contracts and will see benefits for several more years to come. A Q&A with GlobalData’s Peter Shapiro.

Tim Wright, Editor, Contract Pharma 05.05.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News

Clean Biologics Acquires Biodextris

To establish North American presence and expand activities with Biodextris’ complementary services.

Tim Wright, Editor, Contract Pharma 05.05.21

Breaking News | Drug Development | Industry News

Exelixis Acquires GamaMabs Oncology Antibody Program

Gains AMHR2 franchise technology including all assets pertaining to GamaMabs’ monoclonal antibody drug product murlentamab.

Kristin Brooks 05.04.21

Albumedix Extends Research Collaboration with Cobra Biologics

Collaboration investigates enhanced manufacturing of AAV and lentiviral vectors to improve quality and productivity for gene therapy and vaccine developers.

Tim Wright, Editor, Contract Pharma 05.03.21

Breaking News | Facilities | Industry News | Packaging & Tracking

Bushu Pharma Establishes Packaging Center

Expands its gateway to Asia services in partnership with Chuo Unyu Company.

Charles Sternberg, Assistant Editor 04.29.21

PPD to Expand GMP Lab in Ireland

Adding cell and gene therapy capabilities to support growing customer need.

Tim Wright, Editor, Contract Pharma 04.29.21

Breaking News | Cold Chain Management | Collaborations & Alliances | Industry News | Packaging & Tracking

Catalent and Stirling Ultracold Enter Cold Chain Partnership

To establish energy-efficient cold chain capabilities for biologics and emerging modalities.

Tim Wright, Editor, Contract Pharma 04.29.21

ADMA Receives FDA Approval for Increased IVIG Production Scale

Increases plant manufacturing capacity from 400,000L to 600,000L.

Tim Wright, Editor, Contract Pharma 04.29.21

Breaking News | cGMP Manufacture | Industry News

FDA Approves ADMA Biologics Increased IVIG Production

Expanded manufacturing process enables fractionation and purification of a 4,400-liter plasma pool for the manufacture of Intravenous Immune Globulin.

Kristin Brooks 04.28.21

Biologics, Proteins, Vaccines | Breaking News

Introducing ViroCell Biologics

The UK’s first clinical trial focused viral vector manufacturer.

Charles Sternberg, Assistant Editor 04.28.21

Breaking News | Collaborations & Alliances

Bushu, Suzuken Collaboration Expands Services for Specialty Pharmaceuticals

Establishment of new business alliance and facility to provide support for new product launches for manufacturers aiming to enter Japan market.

Tim Wright, Editor, Contract Pharma 04.27.21

Samsung Biologics, TG Therapeutics Expand Manufacturing Collaboration

Expands existing contract manufacturing deal to further enable global manufacture of ublituximab.

Tim Wright, Editor, Contract Pharma 04.27.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News

Bristol Myers Squibb Invests in Cell Therapy Ops

New manufacturing site planned in the Netherlands is the company’s fifth facility dedicated to cell therapy.

Tim Wright, Editor, Contract Pharma 04.27.21

Breaking News | Industry News

Aceto Acquires A&C

Increases its GMP manufacturing, packaging, and ingredients offerings for the cell culture, vaccine, and biopharmaceutical industries.

Charles Sternberg, Assistant Editor 04.27.21

Breaking News | Facilities | Industry News | Inspections

Bora Pharmaceuticals Completes Health Canada Inspection

Mississauga site is the company’s first manufacturing facility in North America and is its HQ in the region.

Tim Wright, Editor, Contract Pharma 04.23.21

Bio News | Bioanalytical Services | Breaking News | Industry News

Waters and Genovis Enter Biopharmaceutical Partnership

Collaboration intended to bring speed and simplicity to bio-characterization workflows.

Tim Wright, Editor, Contract Pharma 04.21.21

Bio News | Breaking News | Industry News

Frontage Acquires Ocean Ridge Biosciences

Expands genomics services through the acquisition deal.

Tim Wright, Editor, Contract Pharma 04.21.21

Bio News | Breaking News | Collaborations & Alliances | Drug Development | Industry News

AGC Biologics Expands Partnership with Rocket Pharmaceuticals

AGG will bolster supply across Rocket’s lentiviral vector (LVV) pipeline, with the manufacture of LVV.

Tim Wright, Editor, Contract Pharma 04.21.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture

Evotec to Build Second Biologics Mfg. Facility in Toulouse

Evotec's first commercial biomanufacturing facility in Europe is anticipated to deliver much needed capacity for biotherapeutic development and manufacturing.

Kristin Brooks 04.20.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News

Resilience Acquires Ology Bioservices

Continues expansion with acquisition of biologics manufacturing company.

Tim Wright, Editor, Contract Pharma 04.19.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News

Abenza Chooses North Carolina for New Biologics Manufacturing Site

GMP manufacturing will commence in mid-2022.

Charles Sternberg, Assistant Editor 04.15.21

Catalent Adds Cryogenic Capabilities at Philadelphia Facility

Bolsters clinical supply services at site to meet growing demand for cell and gene therapy development.

Tim Wright, Editor, Contract Pharma 04.15.21

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News

Catalent Biologics Completes Madison Expansion

More than doubles overall CGMP-scale capacity increasing the number of manufacturing suites at the site to five.

Kristin Brooks 04.13.21

Breaking News

KD Pharma Acquires Manufacturing Assets from Rohner AG

Expands its pharmaceutical contract manufacturing business.

Charles Sternberg, Assistant Editor 04.13.21

Drug Delivery | Logistics

Vetter Packaging Solutions

Vetter can help you identify and develop the right packaging strategies for your compound, from clinical dev to commercialization to life cycle management.

Breaking News | Facilities | Industry News | Solid Dosage/Creams/Ointments

Bora Pharmaceuticals Adds Roller Compaction Capabilities

Installed at Zhunan, Taiwan facility known for manufacturing complex oral solid dose formulations.

Tim Wright, Editor, Contract Pharma 04.09.21

Breaking News | Promotions & Moves

AGC Biologics Appoints Jun Takami GM of Chiba Site

Mr. Takami brings more than 15 years of experience in the pharmaceutical industry.

Kristin Brooks 04.08.21

Analytical Services | Bioanalytical Services | Breaking News | Industry News

Agilex Biolabs Acquires TetraQ for APAC Expansion Plans

Specializes in bioanalysis of small molecules and biologics for PK, immunogenicity, biomarker and immunological pharmacodynamics assessments.

Kristin Brooks 04.08.21

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Fill/Finish | Industry News

Moderna, Catalent Enter Long-Term Strategic Vax Pact

Catalent to dedicate a new high-speed vial filling line for the manufacture of the Moderna COVID-19 Vaccine and potentially other investigational programs.

Kristin Brooks 04.06.21

Bioanalytical Services | Breaking News | CRO News | Industry News

Charles River Acquires Retrogenix

Strengthens scientific expertise with the addition of cell microarray technology and off-target profiling for drug discovery.

Tim Wright, Editor, Contract Pharma 04.05.21

Drug Delivery

The Ever-Evolving World of Combination Products

Looking at the benefits and challenges of the trend towards combination products.

Ricki A. Chase, M.S, Lachman Consultants 04.01.21

Breaking News | Industry News

SK Capital Completes Acquisition of BFS from Catalent Pharma Solutions

Renames the business to Woodstock Sterile Solutions.

Charles Sternberg, Assistant Editor 03.31.21

Breaking News | Industry News | Promotions & Moves

Vibalogics Updates U.S. Leadership Team

Appoints new CFO, VP of quality and head of process sciences.

Charles Sternberg, Assistant Editor 03.31.21

Chime Biologics Expands CDMO Capabilities

Completes $190 million financing round to accelerate capacity expansion.

Tim Wright, Editor, Contract Pharma 03.29.21

Genopis Renamed Wacker Biotech US

Plasmid DNA contract manufacturer was recently acquired by Wacker.

Tim Wright, Editor, Contract Pharma 03.19.21

Breaking News | Industry News | Promotions & Moves

Alcami Names Patrick D. Walsh as Chairman and CEO

35-year pharmaceutical industry veteran brings deep industry expertise and a track record of building successful, client-centric, growth organizations.

Tim Wright, Editor, Contract Pharma 03.19.21

WuXi Biologics to Acquire CMAB Biopharma Group

Will increase 7000L drug substance capacity (MFG21) and drug product capacity (DP11) for liquid and lyophilization within its global manufacturing network.

Kristin Brooks 03.18.21

Promotions & Moves

Alcami Appoints Patrick D. Walsh as Chairman and Chief Executive Officer

He succeeds Walter J. Kaczmarek III, who is stepping down as Chief Executive Officer.

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

Catalent Expands Partnership with J&J

To significantly increase capacity for sterile manufacturing and packaging of COVID-19 vaccine in Italy.

Tim Wright, Editor, Contract Pharma 03.17.21

WuXi Biologics to Acquire Manufacturing Facilities from Pfizer China

Immediately boosts commercial Drug Substance and Drug Product capacities for WuXi Biologics to address surging manufacturing demands.

Tim Wright, Editor, Contract Pharma 03.17.21

Breaking News | Promotions & Moves

Univercells Technologies Names CEO

Mathias Garny to lead the growth and commercialization strategy for biomanufacturing product portfolio and new technology developments.

Kristin Brooks 03.16.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

BioVaxys, Wuxi Biologics Enter Bioproduction Agreement

To synthesize proteins for SARS-CoV-2 vaccine and COVID-T immunodiagnostic programs.

Tim Wright, Editor, Contract Pharma 03.15.21

Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News

Jubilant HollisterStier, Lilly Enter Bamlanivimab Mfg. Pact

COVID-19 therapy Bamlanivimab will be manufactured at Jubilant HollisterStier's Spokane, WA facility.

03.09.21

Bio News | Breaking News | Industry News

Cytovance Biologics Offers Licensing for Plasmid DNA Manufacturing

The Keystone Expression System pDNA platform is an end-to-end solution for manufacturing GMP pDNA at scale.

Tim Wright, Editor, Contract Pharma 03.09.21

Baxter Biopharma Enters Sterile Manufacturing Agreement for Novavax’ COVID-19 Vaccine

Manufacturing to take place at Baxter’s state-of-the-art Halle/Westfalen, Germany facility.

Tim Wright, Editor, Contract Pharma 03.09.21

Breaking News | Collaborations & Alliances

Iontas and Fair Journey Biologics Partner with Quell Therapeutics

Novel target binders from Iontas/FJB will be used to uncover functional antibodies to advance Quell’s engineered Treg cell therapy pipeline.

Charles Sternberg, Assistant Editor 03.08.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News

AGC Biologics Expands Cell and Gene Facility in Italy

Plans call for increased capacities and viral vector suspension capabilities at Milan site.

Tim Wright, Editor, Contract Pharma 03.05.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News

Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie

Continues to build integrated capabilities platform for cell and gene therapy.

Tim Wright, Editor, Contract Pharma 03.05.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News

Fujifilm Breaks Ground on Major Expansion of Biologics Facility in Denmark

Virtual ground-breaking ceremony celebrates initiation of expansion to double cell culture capacity and add large scale fill/finish capabilities.

Tim Wright, Editor, Contract Pharma 03.05.21

Innoforce and dMed Enter Development Collaboration

Aims to accelerate the development of innovative therapeutics.

Tim Wright, Editor, Contract Pharma 03.03.21

Information Technology

5 Reasons Paper Has No Place in Contract Manufacturing

Digital solutions create more efficient manufacturing processes and eliminate delays.

Dave Edwards, Chief Revenue Officer, MasterControl 03.01.21

Drug Delivery | Parenterals

Injectable Drug Delivery Trends

How medication trends are driving the shift to patient-friendly drug delivery systems.

Peter Soelkner, Managing Director, Vetter 03.01.21

Cold Chain Management | Logistics | Packaging & Tracking | Supply Chain

Reshaping the Pharmaceutical Supply Chain

The pandemic and COVID-19 vaccines bring navigating the cold-chain and preserving precious biologics to the forefront.

Kristin Brooks, Managing Editor 03.01.21

Breaking News | Industry News

J&J’s Single-Dose COVID-19 Vax Issued EUA

Phase 3 ENSEMBLE study demonstrated the vaccine was 85 percent effective in preventing severe disease.

Kristin Brooks 03.01.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News

BMS Expands Cell Therapy Manufacturing Capabilities

New state-of-the-art cell therapy manufacturing facility under construction to expand global footprint.

Tim Wright, Editor, Contract Pharma 03.01.21

Catalent Acquires Delphi Genetics

Launches US plasmid manufacturing site to establish global pDNA development and manufacturing capabilities.

Tim Wright, Editor, Contract Pharma 02.23.21

Vetter continues its successful performance at the 2021 CMO Leadership Awards

Winning five core categories reaffirms Vetter as a trusted solution provider, particularly during globally challenging times.

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News

Avid Bioservices Begins Phase 2 of Myford Mfg. Expansion

Build to include second manufacturing train with both upstream and downstream processing suites.

Kristin Brooks 02.22.21

Drug Development

Embedding Your Drug Strategy Within a Solid Foundation for Success

This whitepaper looks at the broad set of trends inﬂuencing pharmaceutical development and manufacturing strategy today.

APIs | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News

FUJIFILM Diosynth Hosts UK PM at COVID Vax Mfg. Site

Billingham site to support the manufacture of up to 180 million doses Novavax’ NVX-CoV2373 COVID-19 vaccine candidate.

Kristin Brooks 02.16.21

Breaking News | cGMP Manufacture | Industry News | Supply Chain

PwC Joins Medicines Manufacturing Innovation Centre

Joins founding partners to address challenges and maximize technology opportunities in the pharmaceutical supply chain.

Kristin Brooks 02.11.21

Breaking News | Industry News

Lonza to Divest Specialty Ingredients Biz

Allows Lonza to focus on its position in the healthcare industry and to accelerate strategic priorities.

Kristin Brooks 02.09.21

Thermo Fisher, JW Therapeutics Form CAR-T Partnership in China

Companies join forces in cell therapy applications and commercial-scale manufacturing.

Tim Wright, Editor, Contract Pharma 02.08.21

Argonaut Opens Custom Controls and Standards Facility

Formulation and filling will be performed at a state-of-the-art site in Carlsbad, CA.

Tim Wright, Editor, Contract Pharma 02.08.21

Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News

Vigene Plans Major Expansion in Maryland

Global gene therapy and vaccine manufacturing company taking additional space in Rockville and adding up to 245 jobs.

Tim Wright, Editor, Contract Pharma 02.08.21

Aseptic Processing | Breaking News | Industry News

Cytiva Acquires Canadian Aseptic Filling Innovator

Deal for Vanrx Pharmasystems supports global trends towards smaller manufacturing and the advent of personalized therapies.

Tim Wright, Editor, Contract Pharma 02.08.21

Catalent, Trizell Enter Cell Therapy Deal

Sign development and manufacturing agreement with for macrophage-based advanced cell therapy.

Tim Wright, Editor, Contract Pharma 02.08.21

Biologics, Proteins, Vaccines | cGMP Manufacture | Drug Development

The Future of Vaccines and Biologics

Dr. Linda Marbán of Capricor Therapeutics discusses the advances in responding to infectious diseases.

Kristin Brooks, Managing Editor, Contract Pharma 02.04.21

Breaking News | cGMP Manufacture

CSafe Global Expands in Asia

Opens two new hub operations in Beijing and Guangzhou, China.

Charles Sternberg, Assistant Editor 02.03.21

Immunome, Abzena Enter COVID-19 Antibody Cocktail Agreement

Abzena will work with Immunome to produce the antibody cocktail for clinical testing.

Kristin Brooks 02.03.21

Cognate BioServices, Nucleus Biologics Form Cell & Gene Therapy Partnership

Will focus on clinical and commercial clients, especially as Cognate expands its business with allogeneic and autologous on-demand cell and gene therapies.

Tim Wright, Editor, Contract Pharma 01.29.21

Novartis Inks Contract Manufacturing Deal for Pfizer-BioNTech COVID-19 Vaccine

Novartis to leverage manufacturing capacity and capabilities to address pandemic, supporting global supply of COVID-19 vaccine.

Tim Wright, Editor, Contract Pharma 01.29.21

Parenterals

Parenteral Drug Delivery Trends

A Q&A with Lubrizol Life Science Health’s CDMO Division President, Rob Lee.

Kristin Brooks, Managing Editor, Contract Pharma 01.27.21

COVID-19 Impact Report

Leaders across the pharmaceutical contract services industry reflect on the impact of COVID-19 in 2020, and what to expect in 2021.

Tim Wright, Editor, Contract Pharma 01.27.21

Almac Expands Global Biologics Testing Services

Investment in mass spectrometry support aims to accelerate biologics development and approval.

Tim Wright, Editor, Contract Pharma 01.27.21

Aphena’s $21M Cookeville Expansion Nears Completion

Bottle packaging capacity has been expanded with the installation of 10 high-speed bottling lines to start.

Kristin Brooks 01.26.21

Breaking News | Collaborations & Alliances

BioMed X, Janssen Enter Oral Drug Delivery Alliance

Aims to discover novel transport mechanisms which could be utilized for oral delivery of therapeutic modalities.

Charles Sternberg, Assistant Editor 01.26.21

Humanigen, Emergent Enter Covid-19 Partnership

Sign contract development and manufacturing agreement for Phase 3 COVID-19 therapeutic candidate lenzilumab.

Tim Wright, Editor, Contract Pharma 01.25.21

Samsung Bioepis Opens New Headquarters

The 52,000-square-foot campus to become the hub of Samsung Bioepis’ drive for accelerated development of next-gen biologic medicines.

Tim Wright, Editor, Contract Pharma 01.25.21

Breaking News | Promotions & Moves

AGC Biologics Appoints Boulder Site GM

David Stewart to oversee the startup, strategic development and operational excellence in large-scale biologics production at the Boulder, CO site.

Kristin Brooks 01.22.21

Biologics and Manufacturing

Syngene offers Biologics development and Biomanufacturing solutions in both mammalian and microbial systems.

Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News

Cognate BioServices Announces Major Expansion

Will increase cell and gene therapy manufacturing capacity, laboratory space, warehousing capabilities and more.

Contract Pharma Staff 01.15.21

Biologics, Proteins, Vaccines | Breaking News | Industry News

Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz

Pays more than $800 million to expand global capacity and address growing demand for cell and gene therapy.

Contract Pharma Staff 01.15.21

Breaking News | Collaborations & Alliances

Charles River Partners with JADE

Expands its biologics testing capabilities geographically and helps to accommodate demand for biologics therapeutics.

Contract Pharma Staff 01.14.21

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News

Cytiva Delivers Modular Biologics Factory to Lonza

Site to become a strategic base in China for Lonza to provide CDMO services throughout Asia Pacific region.

Contract Pharma Staff 01.14.21

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News

Fujifilm, CABIM Get $76M Funding for Mfg. and Innovation Center

FUJIFILM Diosynth Biotechnologies will provide GMP contract process development and manufacturing services as part of its role in the new center.

Contract Pharma Staff 01.14.21

APIs | Breaking News | cGMP Manufacture | Fill/Finish | Industry News

LSNE Expands Fill Finish and Lyophilization Ops

New automated fill line at Bedford Campus adds ready-to-use aseptic filling and freeze-dryer capacity.

Contract Pharma Staff 01.14.21

Catalent Acquires Acorda’s INBRIJA Manufacturing Operations

The CDMO pays $80 million for dry powder inhaler spray drying, capsule manufacturing and packaging operations in Boston area.

Contract Pharma Staff 01.13.21

Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Industry News | Process Development

Capricor, Lonza Enter CAP-1002 Development Agreement

Lonza will perform process development activities for late-clinical and commercial-scale GMP manufacturing of CAP-1002.

Contract Pharma Staff 01.12.21

Baxter, Novavax Ink Sterile Manufacturing Agreement

CMO Baxter will help increase commercial production and promote access to Novavax' Covid-19 vax in UK and European markets.

Contract Pharma Staff 01.11.21

Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News | Information Technology

Leukocare Starts Operations in the US

Opens development laboratories and offices in Boston area.

Contract Pharma Staff 01.11.21

Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News | Laboratory Testing

Biohaven Acquires Remaining Stake in Kleo Pharmaceuticals

Enters exclusive license agreement with Yale University for a novel extracellular degrader technology licensed from Spiegel Lab.

Contract Pharma Staff 01.08.21

Aseptic Processing | Breaking News | Collaborations & Alliances | Parenterals

Catalent Divests Blow-Fill-Seal Sterile CDMO Business

SK Capital makes the acquisition; new independent company to be formed.

Contract Pharma Staff 01.07.21

Alcami Expands Oral Solid Capabilities with Investment in Wilmington, NC

...

Structural Characterization of Biologics Using High-Resolution Mass Spectrometry

High-resolution mass spectrometry is a key component in the characterization of novel biologics and biosimilars.

Fujifilm to Invest $40M in New Facility

State-of-the-art viral vector and advanced therapy process development and manufacturing facility will be located in Boston area.

Contract Pharma Staff 01.05.21

Drug Development | Industry News | Regulatory Affairs

The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

A look at EUA standards and approvals, unavoidable pitfalls, Operation Warp Speed, FDA’s use of Real-World Evidence, and a slow return to "normalcy".

Chad Landmon, Michelle Divelbiss and Alex Alfano, Axinn, Veltrop & Harkrider LLP's Intellectual Property and Food and Drug Administration Practice Groups 01.05.21

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News

AGC Biologics Manufactures Orchard Therapeutics' Libmeldy

European Commission approves one-time therapy for early-onset Metachromatic Leukodystrophy, manufactured at AGC's Milan facility.

Contract Pharma Staff 01.04.21

Analytical Services | Biologics, Proteins, Vaccines | Clinical Trial Materials | Laboratory Testing

Samsung Biologics Continues to Leverage Digitalization to Optimize Client Experience

Through digital transformation, Samsung Biologics is innovating how they connect with clients, regulatory bodies and industry professionals.

Breaking News | cGMP Manufacture

Ajinomoto Bio-Pharma and Revance Therapeutics Partner

Sign manufacturing agreement for supply of DaxibotulinumtoxinA for injection.

Contract Pharma Staff 12.22.20

Breaking News | Industry News | Trials & Filings

Moderna Wins FDA Authorization for COVID-19 Vax

The primary efficacy analysis conducted on 196 cases indicated a vaccine efficacy rate of 94.1%.

Contract Pharma Staff 12.21.20

Abenza Promotes Kimball Hall to President

Hall also joins the Company Board.

Contract Pharma Staff 12.18.20

Bio News | Breaking News | Industry News | Promotions & Moves

Samsung Biologics Names John Rim as President and CEO

Prior to being named chief executive, Rim was executive vice president at the Korea-based CDMO for the past three years.

Contract Pharma Staff 12.16.20

Collaboration Creates Bio Hub in Northern UK

CDMO Fujifilm Diosynth Biotechnologies is part of Northern Bio-Accelerator Partnership.

Contract Pharma Staff 12.16.20

Samsung Biologics Adopts Veeva Vault QMS to Unify Quality Management

CDMO is managing quality processes and content for greater visibility and compliance across global manufacturing.

Contract Pharma Staff 12.16.20

Breaking News | Industry News

AstraZeneca to Acquire Alexion in $39B Deal

Expands scientific presence in immunology by adding Alexion's innovative complement-technology platforms and strong pipeline, and top seller Soliris.

Contract Pharma Staff 12.14.20

Breaking News | Industry News

CPI Scales Up Manufacturing of Pyocin S5

A promising treatment for lung infection in cystic fibrosis patients developed by the University of Glasgow.

Contract Pharma Staff 12.14.20

Breaking News | cGMP Manufacture | Fill/Finish | Industry News | Parenterals

Thermo Fisher Scientific Further Expands Global Footprint

Will expand sites in Greenville, NC; Swindon, UK; and Ferentino and Monza, Italy for sterile drug product development and commercial manufacturing.

Contract Pharma Staff 12.10.20

Bio News | Breaking News | Collaborations & Alliances | Industry News

atbtherapeutics, iBio CDMO Enter Manufacturing Agreement

Will work together for the industrialization of the GMP manufacturing process of atbtherapeutics’ atbodies.

Contract Pharma Staff 12.09.20

Sesen Bio Enters Mfg. and Supply Partnership with Qilu Pharma

Technology transfer to Qilu anticipated to be completed in mid-2021.

Contract Pharma Staff 12.09.20

Breaking News | Industry News | R&D

Colorcon Ventures Invests in i20 Therapeutics

Will work together to accelerate i2O’s research and development efforts.

Contract Pharma Staff 12.07.20

Breaking News | Facilities | Industry News | Information Technology

Samsung Biologics Launches Virtual Showroom

Provides key features and real-time construction updates of its recently announced Plant 4.

Contract Pharma Staff 12.07.20

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News

Keneka Eurogentec Joins Inovio’s Global Mfg. Consortium

Agrees to manufacture Innovio’s Covid-19 vaccine candidate INO-4800.

Contract Pharma Staff 12.03.20

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News

Tubulis, WuXi Biologics and WuXi STA Form Strategic Pact

Will advance a new generation of antibody-drug conjugates towards clinical evaluation.

Contract Pharma Staff 12.03.20

Breaking News | Industry News

AGC Biologics Expands Copenhagen Facility

Increases its production capacity with a total investment of approximately $194.5 million.

Contract Pharma Staff 12.03.20

BD to Invest $1.2B in Pre-Fillable Syringe Manufacturing Capacity

Will roll-out over the next four years and includes a new manufacturing facility in Europe.

Contract Pharma Staff 12.03.20

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

iBio to Provide CDMO Services for ATB Therapeutics

iBio will produce ATB’s bioengineered antibody-toxin fusion proteins.

Contract Pharma Staff 12.03.20

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

Cytovance Expands Partnership with Nature Technology Corp.

Now offers NTC’s proprietary HyperGRO manufacturing platform for plasmid DNA CGMP manufacturing.

Contract Pharma Staff 12.03.20

Breaking News | Drug Development | Promotions & Moves

NeuBase Therapeutics Appoints Chief Scientific Officer

Dr. Curt Bradshaw brings decades of experience in successfully delivering genetic medicines to clinics.

Contract Pharma Staff 12.02.20

Bioanalytical Services | Breaking News | cGMP Manufacture | Industry News

KBI Biopharma Expands U.S. Ops

Invests $150 million in commercial biologics manufacturing facility in RTP, NC.

Contract Pharma Staff 12.02.20

Embion, Asahi Group Enter Strategic Collaboration

Plan to develop new products from brewing by-products generated by Asahi Group.

Contract Pharma Staff 12.01.20

CDMO Stelis Continues Expansion

Starts next phase of investment into its biologics manufacturing facility.

Contract Pharma Staff 12.01.20

Recipharm Inks Covid-19 Vax Pact with Moderna

Signs of letter of intent for aseptic fill-finish manufacturing of Moderna’s COVID-19 vaccine candidate (mRNA-1273).

Contract Pharma Staff 12.01.20

Life Science Success Podcast: Matt Hicks

...

Bio News | Breaking News | Facilities | Industry News

Samsung Biologics Breaks Ground on 'Super Plant'

When completed, the CDMO says it will be the world's largest bio-manufacturing facility.

Contract Pharma Staff 11.24.20

Breaking News | Facilities | Industry News

Abenza Upgrades Chemistry GMP Suites

Appoints new leadership at Bristol PA site.

Contract Pharma Staff 11.24.20

Baxter Invests $50M to Expand Sterile Fill/Finish Manufacturing Operations

Construction currently underway; expected to be completed in 2021.

Contract Pharma Staff 11.24.20

Breaking News | Drug Development | Trials & Filings

Regeneron's COVID-19 Antibody Cocktail Gets EUA

Expects to have treatment doses ready for approximately 80,000 patients by the end of November, and 200,000 by the first week of January.

Contract Pharma Staff 11.23.20

Bio News | Breaking News | Collaborations & Alliances | Industry News

Samsung Biologics Partners with Eli Lilly

Accelerates the delivery of Covid-19 antibody treatments.

Contract Pharma Staff 11.20.20

Promotions & Moves

Catalent Appoints Open Innovation, Biologics, Cell and Gene Therapy VP

Behzad Mahdavi brings more than 20 years of experience in developing and implementing growth strategies in the biopharmaceutical industries.

Contract Pharma Staff 11.19.20

Collaborations & Alliances | Drug Development

Cue Biopharma, Merck Extend Biologics Research Alliance

To develop clinical candidate for the treatment of type 1 diabetes and an additional undisclosed autoimmune disease.

Contract Pharma Staff 11.19.20

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

Asahi Kasei Pharma Contracts ProBioGen

Will use ProBioGen’s technologies for the advancement of its biologics pipeline.

Contract Pharma Staff 11.18.20

Bio News | Breaking News | Industry News

Bionova Scientific Secures First Client Commitment

Its new biologics manufacturing facility is still months from completion.

Contract Pharma Staff 11.18.20

Cell & Gene Therapy Supply Chain: Early Preparation is Key

Supply chain management for cell and gene therapies requires precise demand planning and forecasting.

Matthew Farabaugh, Chief Financial Officer, The Discovery Labs 11.17.20

A Potential “Marriage”

Initiator companies and generics/CMOs working together.

Emil W. Ciurczak, DoraMaxx Consulting 11.17.20

Injectables Firms Expand Capacity

CDMOs see steriles demand grow.

S. Harachand, Contributing Editor 11.17.20

Scale-up/Technology Transfer

Ensuring Quality During the Transfer and Scale Up of Rx Drugs

Defining the key parameters and considerations for a successful technology transfer.

Tom Chang, President, Bora Pharmaceutical Laboratory Co. Ltd. 11.17.20

Bioassay Development | Biologics, Proteins, Vaccines | Drug Development | Facilities

Opportunities in Synthetic Biology

Les Tillack, CEO of Luina Bio, discusses how ‘synbio’ is driving growth in the biopharma industry.

Contract Pharma Staff

Breaking News | Collaborations & Alliances | CRO News

PathoQuest, Charles River Expand Strategic Pact

Establishes a biologics genomic testing laboratory in Wayne, PA to expand next-generation sequencing capabilities.

Contract Pharma Staff 11.12.20

Breaking News | Industry News | Promotions & Moves

Cytovance Appoints CEO

Bin Zhang has been with Cytovance as a member of the Board of Directors since 2018.

Contract Pharma Staff 11.12.20

Bio News | Breaking News | Facilities | Industry News

Stelis BioSource Continues Facility Investment

Will install two 2,000L single-use bioreactor trains in its mammalian CGMP facility.

Contract Pharma Staff 11.12.20

Bioanalytical Services | cGMP Manufacture | Drug Development | Scale-up/Technology Transfer

CDMOs: Keeping up with Science & Technology

Enhancing the development of increasingly advanced and complex drug candidates is needed to drive growth in the industry.

Kristin Brooks, Contract Pharma 11.12.20

Lyophilization

LSNE Contract Manufacturing – The Recognized Leader in Lyophilization and Sterile Manufacturing

A history of execution. A reputation for excellence.

Breaking News | Cold Chain Management | Fill/Finish | Industry News | Vials

Aphena Adds Cold Chain Storage, Biologics Packaging and Distribution

Expansion includes 14,000 cold chain pallet spaces in new 500K-sq.-ft. facility.

Contract Pharma Staff 11.11.20

AC Immune and WuXi Biologics Expand Strategic Partnership

Plan to accelerate AC Immune’s TDP-43 antibody into clinical development.

Contract Pharma Staff 11.10.20

Gilead Bolsters Biologics Capabilities

Licenses ProteoNic’s 2G UNic Technology Platform for production of biologics.

Contract Pharma Staff 11.10.20

Breaking News | Drug Development | Promotions & Moves

Inozyme Pharma Appoints SVP, Regulatory Affairs

Dr. Kevin B. Johnson brings over 25 years of experience to the role.

Contract Pharma Staff 11.09.20

Fareva Expands Sterile Production Capabilities

Grows footprint with site acquisition in France and Austria.

Contract Pharma Staff 11.06.20

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Drug Development | Industry News

Jubilant Radiopharma, SOFIE Biosciences Ink Strategic Pact

Jubilant will be a strategic partner to SOFIE enabling SOFIE to expand production capacity and advance its theranostic pipeline.

Contract Pharma Staff 11.04.20

Bio News | Breaking News | Collaborations & Alliances | Industry News

TFF Expands Engagement with Experic

Agrees to install a TFF processing line and its associated capabilities at Experic’s cGMP facility in NJ.

Contract Pharma Staff 11.03.20

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

Samsung Biologics Expands in China

Partners with Chinese biotech GeneQuantum Healthcare on ADC development.

Contract Pharma Staff 11.03.20

Bio News | Breaking News | cGMP Manufacture | Industry News

eTheRNA Extends mRNA Production Services

Adds high throughput research grade mRNA to its GMP capabilities.

Contract Pharma Staff 11.03.20

Breaking News | Industry News

Samsung Biologics, Checkpoint Therapeutics Expand Cosibelimab Mfg. Pact

Samsung Biologics will provide additional commercial-scale drug substance manufacturing.

Contract Pharma Staff 11.02.20

Bio News | Breaking News | Drug Development | Facilities | Industry News

Samsung Biologics Expands Global Footprint

Opens new San Francisco CDO R&D Center.

10.30.20

Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances

AB2 Bio and WuXi Biologics Enter Collaboration

Set-up and accelerate commercial-scale manufacturing of Tadekinig alfa.

Contract Pharma Staff 10.29.20

DOD Awards Ology Vaccine Manufacturing Contract

CDMO to manufacture and test novel live attenuated tularemia vaccine candidate.

Contract Pharma Staff 10.28.20

Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News

MolMed S.p.A Becomes AGC Biologics S.p.A

AGC Biologics now provides end-to-end cell and gene therapy CDMO services.

Contract Pharma Staff 10.28.20

Breaking News | Industry News

Stevanato, Catalent Partner to Expedite Equipment Installation

Stevanato’s high-speed visual inspection machines will support biologic and vaccine programs at Catalent manufacturing sites in U.S. and Italy.

Contract Pharma Staff 10.27.20

3P Biopharmaceuticals and SpyBiotech Enter Vaccine Contract Manufacturing Agreement

Looking towards completing production in 2021.

Contract Pharma Staff 10.26.20

Breaking News | Collaborations & Alliances | Facilities | Industry News

Construction Starts on the Medicines Manufacturing Innovation Center

Will offer next-gen solutions in small molecule and pharmaceutical manufacturing.

Contract Pharma Staff 10.26.20

Breaking News | Facilities | Industry News | QA/QC

Wuxi Griffin Completes Investment in New QC Lab and Storage Facility

Offers fully equipped microbiology and analytical testing lab for bulk and final product testing.

Contract Pharma Staff 10.26.20

Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances

ABEC Delivers Process Systems to Ology Bio

Supports production of critical vaccines and therapeutics for COVID-19.

Contract Pharma Staff 10.22.20

Clinical Trials | Drug Development | Preclinical Outsourcing

Accelerating R&D Trends

The pandemic has propelled lingering trends into the forefront and increasingly complex molecules and biologics have drug developers outsourcing more.

Kristin Brooks, Contract Pharma 10.20.20

APIs | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News

JSR Life Sciences Expands European Footprint

Will co-locate primary European operations for affiliate companies KBI Biopharma and Selexis SA in Geneva’s ZIPLO campus.

10.20.20

Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development

Samsung Biologics, Dinona Partner on Potential COVID-19 Antibody Therapy

Will collaborate for fast-track development of DNP-019, a potential COVID-19 antibody therapy.

10.20.20

APIs

Emphasizing Sustainability in Contract Manufacturing

Ajinomoto Bio-Pharma Services outlines its commitment to protecting the environment.

Contract Pharma Staff

Bio News | Breaking News | Collaborations & Alliances | Industry News

Antegene, WuXi Biologics Enter Oncology R&D Alliance

To collaborate on the development and production of novel drugs, and jointly promote the R&D of innovative oncology therapies in China.

Contract Pharma Staff 10.19.20

Promotions & Moves

Touchlight Appoints CEO

Karen will work to further expand the company's contract manufacturing business, which delivers GMP materials to third parties developing COVID-19 vaccines.

Contract Pharma Staff 10.16.20

Breaking News | Industry News | Promotions & Moves

Vigene Biosciences Appoints COO

Molly McGlaughlin brings 27 years of experience in biologics manufacturing and development.

Contract Pharma Staff 10.15.20

Capsules | Solid Dosage/Creams/Ointments

Capsule Technology Trends

A look at the capsule market with a particular focus on the factors driving increased demand in non-gelatin-based formulations.

Julien Lamps, Product Manager, Lonza 10.14.20

Aseptic Processing | Fill/Finish

A Holistic Cleanroom Concept: Higher Quality and Greater Flexibility

Overcoming today’s aseptic fill-and-finish process challenges.

Ute Schleyer, Project Manager, Site & Plant Development, Vetter 10.14.20

The Pandemic’s Become an Insurmountable Opportunity

Every Cloud has a Silver Lining(?)

Emil W. Ciurczak, Contributing Editor 10.14.20

Analytical Services | Bioanalytical Services | Breaking News | Industry News | Laboratory Testing

PPD to Open Multipurpose Clinical Research Lab in Suzhou

Will offer bioanalytical, biomarker and vaccine services for global and China-based biopharma customers.

10.14.20

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

KindredBio Expands Manufacturing Agreement with Vaxart

Centaur will manufacture Vaxart’s oral vaccine for COVID-19 and other vaccine candidates.

Contract Pharma Staff 10.13.20

Biologics, Proteins, Vaccines | Breaking News | Industry News

MilliporeSigma Launches VirusExpress Platform

Scalable platform increases dose yields and reduces process development time for cell and gene therapies.

10.13.20

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

Fujifilm Diosynth to Manufacture Lilly COVID-19 Antibody

Commercial manufacturing of the antibody therapy is expected to commence in April 2021.

Contract Pharma Staff 10.13.20

Breaking News | Facilities | Industry News | Injectables | Packaging & Tracking

Sharp Invests $10M in Biologics, Injectables Packaging Equipment

Investment includes the installation and validation of two Dividella NeoTopx packaging systems.

Contract Pharma Staff 10.13.20

Breaking News | Industry News | Inspections

Symbiosis Completes MHRA Regulatory Inspection

Scottish CMO recorded no critical or major observations from the reinspection by the MHRA.

Contract Pharma Staff 10.13.20

cGMP Manufacture | Drug Development | Promotions & Moves

AGC Biologics Appoints New GM of Milan Site

Luca Alberici will initiate integration efforts resulting from the July 2020 acquisition of MolMed.

Contract Pharma Staff 10.12.20

Breaking News | Collaborations & Alliances | Drug Development | R&D

Antengene, WuXi Biologics Ink Innovative Oncology R&D Alliance

Partner for the development and production of novel drugs, and to jointly promote R&D of innovative oncology therapies.

Contract Pharma Staff 10.12.20

Abzena Invests $60M Into cGMP Manufacturing Capacity

New facility in San Diego houses a process development laboratory and two new cGMP manufacturing cleanrooms.

Contract Pharma Staff 10.08.20

Biologics, Proteins, Vaccines | Breaking News

Kindred Bio Expands Agreement with Vaxart

Centaur will manufacture Vaxart’s oral vaccine for COVID-19 and other vaccine candidates.

Contract Pharma Staff 10.07.20

Biologics, Proteins, Vaccines | Breaking News

FDA Issues Guidance on EUA for COVID-19 Vaccines

Provides further information on the EUA process for investigational vaccines.

Contract Pharma Staff 10.07.20

Breaking News | R&D

Samsung Biologics Adopts Solentim Solutions in R&D Center

Solentim’s instruments will be used in conjunction with Samsung Biologics’ proprietary cell line platform.

Contract Pharma Staff 10.07.20

Breaking News | Collaborations & Alliances | Industry News

Irisys Signs Contract with TFF Pharma

Will produce medication to treat lung conditions, including COVID-19.

Contract Pharma Staff 10.06.20

Breaking News | Promotions & Moves

Abenza Appoints SVP and Site Head

Giovanni Escobar brings over 27 years’ experience in the Pharmaceutical industry.

Contract Pharma Staff 10.06.20

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

iBio Enters into Agreement with Safi Biosolutions

To develop growth factors and cytokines using the FastPharming system.

Contract Pharma Staff 10.06.20

Breaking News | Industry News

Formulated Solutions Receives Three ISO Certifications

Company is also pursuing ISO13485:2016 Medical Devices Quality Management Systems.

Contract Pharma Staff 10.06.20

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

GT Biopharma and Cytovance Biologics Expand Partnership

Cytovance will be the exclusive GMP manufacture for three of the company's TriKE therapeutic product candidates.

Contract Pharma Staff 10.06.20

Breaking News | Collaborations & Alliances | Drug Development

Diamond Pharma Services Supports GenSight Biologics

Provides EU regulatory, pharmacovigilance, quality and compliance support for LUMEVOQ.

Contract Pharma Staff 10.05.20

Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News

Cobra Biologics to Manufacture Plasmids for COVID-19 Vax Trial

Collaboration will ensure GMP production of material for Phase I clinical trial of Scancell’s DNA vaccine against SARS-CoV-2.

Contract Pharma Staff 10.05.20

Breaking News | Promotions & Moves

3P Expands Management Team

Adds José Luis Bartolomé as operational excellence and continuous improvement director.

Contract Pharma Staff 10.02.20

Breaking News | cGMP Manufacture | Industry News | Parenterals | QA/QC

Lonza Expands QC Testing Portfolio

Launches PyroCell MAT System for in vitro Pyrogen testing to help ensure safety of parenteral pharmaceuticals during development, manufacture and release.

Contract Pharma Staff 10.01.20

Bioanalytical Services | Breaking News | Industry News | Laboratory Testing

Almac Launches Biologics Testing Services

New services include GMP lot release and stability testing to support drug substance and drug product programs for biologics and biosimilars.

Contract Pharma Staff 09.25.20

Catalent Acquires New Biologics Facility

Creates North American clinical manufacturing center of excellence.

Contract Pharma Staff 09.24.20

Bio News | Breaking News | Collaborations & Alliances | Industry News

Samsung Biologics Signs Deal with Kanaph Therapeutics

To develop treatment for retinal diseases.

Contract Pharma Staff 09.24.20

Bio News | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News

Samsung Biologics and AstraZeneca Ink Manufacturing Deal

Partnership for global supply could be worth more than $545 million.

Contract Pharma Staff 09.22.20

Breaking News | cGMP Manufacture | Collaborations & Alliances

PharmAbcine Partners with Samsung Biologics for PMC-403

The antibody is expected to enter a global ophthalmological clinical trial in 2022.

Contract Pharma Staff 09.21.20

Samsung Biologics Inks Service Pact with Panolos Bioscience

Will provide cell line development, process development, and clinical material manufacturing for PB101, an Fc-fusion protein to treat solid tumors.

Contract Pharma Staff 09.17.20

Aseptic Processing | Lyophilization

Planning and Executing a Media Fill: A Guide to Aseptic Process Validation for Lyophilized Products

This webinar from Lubrizol Life Science on Nov 4 will explore key considerations in designing and executing aseptic process simulations for lyophilized products

09.10.20

Cobra Biologics and CombiGene Partner

Sign agreement to secure GMP production of plasmids for production of CG01 gene therapy.

Contract Pharma Staff 09.10.20

Breaking News | Facilities | Industry News | Solid Dosage/Creams/Ointments

Swiss American CDMO Expands in Texas

Adds new 131,760 square-foot industrial facility.

Contract Pharma Staff 09.03.20

Bio News | Bioassay Development | Breaking News | Industry News

Adma Biologics Launches COVID-19 Assay

Detects SARS-CoV-2 neutralizing antibodies in plasma.

Contract Pharma Staff 09.03.20

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

HJB and Ansun Biopharma Enter Biologics Collaboration

CMC development and manufacturing partnership expecting to submit an IND application in 2021.

Contract Pharma Staff 09.01.20

Mapp Biopharma Partners with CDMO Avid Bioservices

For clinical development of novel human monoclonal antiviral antibody.

Contract Pharma Staff 08.26.20

Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News

CDMO Ology Bioservices Gets $106.3M U.S. Army Contract

To reserve production capacity in support of Operation Warp Speed.

Contract Pharma Staff 08.26.20

Bio News | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News

AGC Biologics Completes PPQ Mfg. Campaign with Provention Bio

For type 1 diabetes product candidate, teplizumab.

Contract Pharma Staff 08.26.20

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News

Maravai LifeSciences Expands CDMO Capabilities at TriLink

To increase small molecule manufacturing capacity for additional scale-up of CleanCap messenger RNA capping technology for vaccine and therapeutic programs.

Contract Pharma Staff 08.25.20